Results 191 to 200 of about 2,433,705 (252)
Some of the next articles are maybe not open access.

Complexities of HBV DNA integration

Hepatology, 1989
Morris Sherman, Tim J. Harrison
openaire   +2 more sources

Treatment decisions based on HBV DNA

Journal of Viral Hepatitis
AbstractThe most common cause of hepatocellular carcinoma (HCC) worldwide is chronic hepatitis B virus (HBV) infection (CHB). Long‐term suppression of HBV replication by antiviral treatment reduces the risk of HCC and mortality. Nonetheless, only 2.2% of CHB patients globally received the treatment in 2019.
openaire   +2 more sources

[Intrauterine HBV infection: risk factors and impact of HBV DNA].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008
To investigate the risk factors of intrauterine hepatitis B virus (HBV) infection and the impact of HBV DNA on the infection.The serum levels of HBsAg, HbsAb, HBeAg, HBeAb, HBcAb and HBV DNA were determined in blood samples from 230 HBsAg-positive pregnant women and their newborns by enzyme-linked immunosorbent assay (ELISA) and fluorescence ...
Yu-zhu, Yin   +4 more
openaire   +1 more source

HBV DNA in blood donors

Transfusion, 1988
C, Ferec, C, Verlingue, J P, Saleum
openaire   +2 more sources

Quantitation of HBV covalently closed circular DNA (HBV CCC DNA) in HCC patients

2010
Objective: Hepatitis B virus (HBV) is a major causative agent of hepatocellular carcinoma (HCC). We aimed to use the Invader assay to measure the intrahepatic total HBV DNA and covalently closed circular (ccc) DNA in the tumorous and non-tumorous tissues of HCC patients.
Sum, SM   +4 more
openaire   +1 more source

Recognition of HBV antigens and HBV DNA by dendritic cells.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2011
Hepatitis B virus (HBV) is a hepatotropic, noncytopathic, DNA virus which can cause acute and chronic infection. Viral persistence is associated with a weak or absent specific immune responses to HBV, particularly the cellular immune response. Dendritic cells (DCs) are professional antigen-presenting cells with a unique T cell stimulatory aptitude that
Guang-Ying, Cui, Hong-Yan, Diao
openaire   +1 more source

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Michael L Cheng   +2 more
exaly  

DNA microarray technology in HBV genotyping

Minerva Medica, 2017
Payam, Behzadi   +2 more
openaire   +2 more sources

Clinical uses of HBV-DNA assays

Journal of Virological Methods, 1985
H C, Thomas   +3 more
openaire   +2 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Home - About - Disclaimer - Privacy